Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Dong

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Bioorganic & Medicinal Chemistry Letters|March 29, 2018
Discovery of 4-ethoxy-7H-pyrrolo[2,3-d]pyrimidin-2-amines as potent, selective and orally bioavailable LRRK2 inhibitorsXiao Ding, Luigi Piero Stasi, Ming-Hsun Ho, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2018
5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacyXiao Ding, Luigi Piero Stasi, Xuedong Dai, et al.
RSC Medicinal Chemistry|December 15, 2025
Discovery and optimization of pyrrolopyrimidines as highly potent, selective and brain-penetrant LRRK2 inhibitorsJeffrey M Axten, Xiao Ding, Luigi Piero Stasi, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2017
Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitorsXiao Ding, Xuedong Dai, Kai Long, et al.
Bioanalysis|April 13, 2021
Recommendations for the content and management of Certificates of Analysis for reference standards from the GCC for bioanalysisJoseph Bower, Jennifer Zimmer, Stacie McCown, et al.
Bioanalysis|June 12, 2024
16<sup>th</sup> GCC Closed Forum: ICH M10 implementation; NGS, qPCR/dPCR, flow cytometry validation; tissue biomarkers; IS response; immunogenicity harmonization; bioanalytical industry statusJennifer Zimmer, Amanda Hays, Todd Lester, et al.
Bioanalysis|February 9, 2022
Recommendations on ELISpot assay validation by the GCCRafiq Islam, Jennifer Vance, Martin Poirier, et al.
Bioanalysis|April 18, 2025
Recommendations on biomarker assay validation (BAV) in tissues by GCCMoucun Yuan, Aihua Liu, Bin Xu, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Bioorganic & Medicinal Chemistry Letters|March 29, 2018
Discovery of 4-ethoxy-7H-pyrrolo[2,3-d]pyrimidin-2-amines as potent, selective and orally bioavailable LRRK2 inhibitorsXiao Ding, Luigi Piero Stasi, Ming-Hsun Ho, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2018
5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacyXiao Ding, Luigi Piero Stasi, Xuedong Dai, et al.
RSC Medicinal Chemistry|December 15, 2025
Discovery and optimization of pyrrolopyrimidines as highly potent, selective and brain-penetrant LRRK2 inhibitorsJeffrey M Axten, Xiao Ding, Luigi Piero Stasi, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2017
Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitorsXiao Ding, Xuedong Dai, Kai Long, et al.
Bioanalysis|April 13, 2021
Recommendations for the content and management of Certificates of Analysis for reference standards from the GCC for bioanalysisJoseph Bower, Jennifer Zimmer, Stacie McCown, et al.
Bioanalysis|June 12, 2024
16<sup>th</sup> GCC Closed Forum: ICH M10 implementation; NGS, qPCR/dPCR, flow cytometry validation; tissue biomarkers; IS response; immunogenicity harmonization; bioanalytical industry statusJennifer Zimmer, Amanda Hays, Todd Lester, et al.
Bioanalysis|February 9, 2022
Recommendations on ELISpot assay validation by the GCCRafiq Islam, Jennifer Vance, Martin Poirier, et al.
Bioanalysis|April 18, 2025
Recommendations on biomarker assay validation (BAV) in tissues by GCCMoucun Yuan, Aihua Liu, Bin Xu, et al.
Pageof 6